{"name":"Enveda Therapeutics","slug":"enveda-therapeutics","ticker":"","exchange":"","domain":"enveda.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-04-05","type":"trial","source":"Indian Pharma Post","summary":"Enveda’s experimental oral therapy shows breakthrough results in atopic dermatitis trial - Indian Pharma Post","headline":"Enveda’s experimental oral therapy shows breakthrough results in atopic dermatitis trial","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxPX3d2emx3WDNwS3BWTk9nQ0otX2YydUdJQ1RuckRpVmtSVktXZVdUc2VoODk4UlEzTzFUQkFReTROZW9iZ29rdmZVME94R0JmV2FIQkNZdjQ0MkVIWThGQXI0LUY1bUJPTFV0NEpvZDVpbmpPYXNSMXNOR0sxakotTnJFaGY2WUl2VHc?oc=5","date":"2026-03-31","type":"trial","source":"Endpoints News","summary":"Exclusive: In promising early readout, Enveda shows Dupixent-rivaling potential in atopic dermatitis - Endpoints News","headline":"Exclusive: In promising early readout, Enveda shows Dupixent-rivaling potential in atopic dermatitis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxQUGR2LTZ6OUtkelJNT2RLSS12bGxFd04wdnQ4UU1fNWtHT1ozYzNoaDY0U0c1T3dZOGNKYktkVVdaaE9scmNWdXJsRnY2ZUMtZ0ROQ1FPZ050M2JMUThILXdmVUVZbjNsSkpPTWJYaU80R254S1BtZTRtZEpxYTFuYg?oc=5","date":"2026-03-24","type":"pipeline","source":"Fast Company","summary":"The most innovative biotech companies of 2026 - Fast Company","headline":"The most innovative biotech companies of 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxQRmJVbjlxZlo5VjFyanhielhqSGY5bTkyc0tacFRsRWgzX2VrU2RGcnpxQWgySGtWd0RaTGNsaXptWTR3U0hFOUNtRFM0NXY3V0FIclhMQ2lkZ19IeHZWenlkenYxd3JldjV0RmVQSHpyTWlCaEVuNFRkekktNE92ejZQX05lc3NfaE1XRUtmUXJyTTdmWnFlRUFxN0EtRWRjaEFaRzhMSGJTOWVMVW9lcXNTd0xVMktGc2Zj?oc=5","date":"2026-01-14","type":"deal","source":"Contract Pharma","summary":"Phlow, Enveda Share Progress on AI-Powered API Manufacturing Collaboration - Contract Pharma","headline":"Phlow, Enveda Share Progress on AI-Powered API Manufacturing Collaboration","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6AFBVV95cUxPM0hMOWFaNDJSRklqUzVaa2VUakp5QjBTVEJuUjVPNXJ4RjZKdERkdlZNZDZyUW1MMDhuR0FaUXlHSXZMOUJKN1hwbHd4cGhTTWRKTEJuWGpjWW1IbHIzcnJfYUYzQmFFRzJIWjZuZ280VnE1TGFEZm1SdHZpeHIzUkNPckFaSjYxSzlXSGhWOFF4RnR6SzB4cTJoQW5HMm1CX0hhb0NOa2hVNUFnUG1QYTJ3TXowZ1ROa2FyRm9WekQtX25NYmxNM0lsRm1yakF4b2FtUXFXZ3JsRTlHekNnV3VMZkE3MmRx?oc=5","date":"2025-12-10","type":"trial","source":"BioSpace","summary":"Enveda Initiates Phase 2 Clinical Trials of ENV-294, a First-in-Class Oral Therapy in Atopic Dermatitis and Asthma - BioSpace","headline":"Enveda Initiates Phase 2 Clinical Trials of ENV-294, a First-in-Class Oral Therapy in Atopic Dermatitis and Asthma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiW0FVX3lxTE5QMlFfTHFPWTZhVWI2NnFfTktLc25pR2ZLZTk3WUx3cjh0dERzU2YxM2JIRWt0Y0I3eS1xalNXUEh2NWR4aXMzQjF2b3BUQ2lsQWhPZDJSdUlqRTg?oc=5","date":"2025-11-21","type":"pipeline","source":"Failory","summary":"Top 100 Pharmaceutical Startups to Watch in 2026 - Failory","headline":"Top 100 Pharmaceutical Startups to Watch in 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQeEh6RUE2LXYxT2ZqVElKbVRqYXJTQl9IeFBaNklSdXdOQ1FNekY3RFV5ekxWQUpSUDlCcWpZUHNiT1hRODJsQzk3a1d6LWo4VVlTYnVZSzRYY2FnUThBSkNwd29TNE16elVwdkJDOUtLT21pMXRXSTNOZHVEM3pLS21uR3N0NUtRc1pUMzBuaW4?oc=5","date":"2025-09-04","type":"pipeline","source":"BioPharma Dive","summary":"A drug discovery startup banks $150M for immune and obesity drugs - BioPharma Dive","headline":"A drug discovery startup banks $150M for immune and obesity drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNZmx5dkxmOV9RUm1VcTQ4Z0VZckE1TWJlVVQxRkhaNFBrSlJaTy01cmRJNEpaUEtST3VRTzVGRmtKSmNwSHhVUC1pR0VqR3JQSXZPZ0MxWHQzUzZXdXU3SzFzelJSWWNWMTB0Z2tnUDhMLUJjcWpKbW5yMDJNQ0RmWG94NVVSWm83TXN5MzBfclgwN2tWQ0Qxc0JPc3A?oc=5","date":"2025-09-04","type":"pipeline","source":"Fierce Biotech","summary":"Enveda harvests another $150M to advance nature-inspired drugs - Fierce Biotech","headline":"Enveda harvests another $150M to advance nature-inspired drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxOM20wOG1WUHkyT0xJanRVbEVNR2xZTEFyRkozOHAzZmNMeG43SEtmQzlfeXVxcDZaWDl5bWx3UjR2aVNuYWtWU3ZKamd6cTRPaEhfSDRsTVFVWVVUbDFyeGxUWDR5WHRVTi1FUXRNN19JYlU4WWZfQWFlVExIZF9TeVZ0ZDF1MEZUOExTTElHdC1VNXlTUGRQLWVDWnBnUkNfV29kVzRMam1kQ1Q2V1MtMFA4VXF5dw?oc=5","date":"2025-09-04","type":"pipeline","source":"Bloomberg.com","summary":"Biotech’s Latest Unicorn Uses AI to Mine Nature’s Medicine Chest - Bloomberg.com","headline":"Biotech’s Latest Unicorn Uses AI to Mine Nature’s Medicine Chest","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwJBVV95cUxQVjdhdnlLR2ZLc2tFeGg1OS12eFlFZzZwanpCSVVERDBlNTVheWtvT0VxUVZ5VmY3QlJnZ1FaVTZVdmNMOFJNcEJWVmJ1Tlk3S3VfRkF0WW9vTjh0NlVidncxRGNzODVKUVBBRFJwWHFuWFk4N1Z4ZDNJdW9RNkpKRlkwSnJEWUgxZ1hjSWhObFpjWW1XTDBJbGVKX3NiRkUtZEJhLTBrMjZ0MnFpV05LZXlORDlNSlk5YzJpcExsZVRwVXhldFdLVTVmNXdiRDYtLTlaVzVlT0VvVk5oQmFHMDk2V0lVR0ctb1EzVVFIVHpsSU84bDdEMm9rT0lveWV4QjVUSkNyWHBnNFFQTVpuS0xiMnQwZWJLbmJ5a1dJYThiRTBKcHdqcFZIaw?oc=5","date":"2025-09-04","type":"pipeline","source":"Business Wire","summary":"Enveda Raises $150M Series D Funding to Reach Unicorn Status, Enrolls First Patient in Lead Program, and Adds Mikael Dolsten to Board of Directors - Business Wire","headline":"Enveda Raises $150M Series D Funding to Reach Unicorn Status, Enrolls First Patient in Lead Program, and Adds Mikael Dol","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxQVk1XSVRuckYwUXVjQTEwb1VCOGlFWHZIYk1fTnpyM1JUZ0R2Z0dRblNXOS1MWS1zdmh3NGpidVdUYW5yLWRkR1RVQ3lCQUhnV0NWMmRSRFJNbEdOckhSNkloTzFrRlZfRkdydlVhdFBycEpiVTBVQTEtcExjVTRza0oyY1ZwSTdtbXBuRXY2MXduY2JCVVlMNUhn?oc=5","date":"2025-09-04","type":"pipeline","source":"The Business Journals","summary":"Boulder biotech claims unicorn status with $1B valuation - The Business Journals","headline":"Boulder biotech claims unicorn status with $1B valuation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxPcUNaR0dBVlhUcXhsY3Vxc0k2VURBWmpNYm1nNExqRExQLWJRejd6Nm9BVUlSN0t0bW5mUVlzQ3p1NFpRdEhTbXhaZHA5cUhfczFKOW1POTQ2UnRTTVpyZ1g2VEJkdDNOMW0yODlMc0ZVS19yZS1iMGlIVnJKZEJScXgzU1dFLTQ4VlJ2UVl2ZFJOZFRaOWkwR0FyNTRhd2ZrYjV0YkhrZWFZMGU2MHQ2TQ?oc=5","date":"2025-07-28","type":"pipeline","source":"Fierce Pharma","summary":"Chiesi, Viatris among collaborators on BIO's latest BBC-produced video series - Fierce Pharma","headline":"Chiesi, Viatris among collaborators on BIO's latest BBC-produced video series","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}